Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO.MOUNJARO® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022
Medication labelWhy this: Advisory · dailymed-prescription
MOUNJARO® is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.
- generic_name
- tirzepatide
- product_names
- tirzepatide
- ndc
- 50090-8023, 0002-1484, 50090-8023-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en